Summary. Oestrogen action in the uterus is expressed in an early phase (Phase I) 
Introduction
Ovarian progesterone and oestrogen are required for implantation in the mouse. Ovariectomy before the presumed oestrogen surge on Day 4 of pregnancy results in dormancy of the blastocyst and delayed implantation (Yoshinaga & Adams, 1966; McLaren, 1973; McCormack & Greenwald, 1974) . Implantation can be initiated, however, if the animals are pretreated with progesterone followed by a single injection of oestrogen (Yoshinaga & Adams, 1966; McLaren, 1973) . This model has been shown to be very sensitive for testing oestrogenicity of compounds and determining their mechanism of action. In the uterus, oestrogen action has been characterized as an early phase (Phase I) and a late phase (Phase II) (Astwood, 1939; Kirkland et al, 1977; Harris & Gorski, 1978; Galand et al, 1983) . The role of this biphasic oestrogen action in implantation remains undefined.
Phase I effects occur within 6 h and fluid imbibition is one of its predominant characteristics. Phase II or true growth phase is characterized by hyperplasia and hypertrophy and occurs within 18-30 h (Kirkland et al, 1977; Harris & Gorski, 1978; Galand et al, 1983) . Our objectives were to search for compounds that would show either Phase I, Phase II or both phases of oestrogenic responses and to determine their relative importance in the initiation of implantation. In ovariecto¬ mized animals, oestradiol-17ß expresses characteristics of both phases, whereas oestriol, when administered as a single injection, induces mainly Phase I responses (Clark et al, 1977; Kirkland et al, 1977; Harris & Gorski, 1978; Galandefa/., 1983) . Triphenylethylene compounds are generally considered to be antioestrogens because of their capacity to antagonize oestrogen responses in the target organs. However, these compounds possess weak inherent oestrogenicity and can manifest partial agonistic responses in the uterus (Katzenellenbogen & Ferguson, 1975; Gardner et al, 1978; Black & Goode, 1980; Clark & Markaverich, 1982) . Although as agonists they show some uterine growth, it has not been documented whether they can induce biphasic responses. We have studied different kinds of oestrogens (oestriol and oestradiol-17ß) and triphenylethylene compounds (CI-628, nafoxidine, tamoxifen, LY-117018, (Psychoyos, 1973 
Results
None of the oestrogens or triphenylethylene compounds produced increases in uterine dry weights at 24 h (a Phase II response) but rather decreased it when compared to progesterone treatment only (Fig. 1) Fig. 1 . the compounds tested, clomiphene citrate was the least effective in eliciting fluid imbibition at 6 h (a Phase I response) under the same conditions (Fig. 2) and also in initiating implantation in delayed implanting mice (Fig. 3) . With increasing doses of oestriol from 50 to 250 ng the percentage of mice with implantation sites increased to a full complement. The overall efficacy of the different compounds was measured by the proportion of animals with implantation and, better, by the total number of implantation sites in a same number of mice (Fig. 4) . This reveals a strong correlation of this response with fluid imbibition under the same conditions. Although not shown, CI-628, nafoxidine and LY-117018 were effective in inducing implantation at dose ranges of 5-250 µg, whereas tamoxifen was effective only at the dose shown here. Clomiphene citrate at doses above (125 µg and 250 µg) and below (1 µg) those shown ( Fig. 3 ) also had poor implantation-inducing abilities. Furthermore, neither LY-117018 nor CI-628 was able to inhibit oestrogen-induced implantation. LY-117018 (125 µg/mouse) injected 30 min before and 4 h after oestradiol-17ß (lOng/mouse) resulted in implantation in 86% of the mice (N = 7) with a mean (Ts.e.m.) of 8-3 ± 0-9 implantation sites. When given only 30 min before oestradiol-17ß, the same compound showed implantation in 100% of the mice (N = 5) with a mean of 5-8 + 1-9 implantation sites. Injection of CI-628 (250 µg/mouse) followed by oestradiol-17ß (10 ng/mouse) 30 min later induced implantation in 100% of the mice (n = 7) with a mean number of implantation sites of 61 + 1-3.
Discussion
In general multiple injections of test compounds are used in ovariectomized or immature rats and mice without progesterone priming for determining their oestrogenic or antagonistic responses in the uterus (Katzenellenbogen & Ferguson, 1975; Clark et al, 1977; Gardner et al, 1978; Black & Goode, 1980; Clark & Markaverich, 1982) . In the non-progesterone primed rodent uterus, oestradiol has been shown to possess characteristics of both Phase I and Phase II, while oestriol as a single injection, exhibits only the former (Clark et al, 1977; Kirkland et al, 1977; Harris & Gorski, 1978; Galand et al, 1983) . However, progesterone-priming of the uterus is an absolute requirement for oestrogen to initiate implantation (Yoshinaga & Adams, 1966; McLaren, 1973; Psychoyos, 1973 (Nelson et al, 1963; Sengupta et al, 1979 (Finn & Martin, 1974) .
